RNS Number:4355F
Powderject Pharmaceuticals PLC
20 December 2002
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
POWDERJECT PHARMACEUTICALS PLC
2) NAME OF DIRECTOR
DR PAUL DRAYSON
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS IN 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
7) Number of shares/amount of
stock acquired
8) (N/A %)
of issued Class
9) Number of shares/amount
of stock disposed
10) ( N/A %)
of issued Class
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
20 DECEMBER 2002
18) Period during which or date on which exercisable
1 FEBRUARY 2006 - 31 JULY 2006
19) Total amount paid (if any) for grant of the option
#250.00 TO BE PAID MONTHLY FROM 1 FEBRUARY 2003 UNTIL 1 JANUARY 2006
UNDER POWERJECT PHARMACEUTICALS PLC SHARESAVE SCHEME
20) Description of shares or debentures involved: class, number.
3214 ORDINARY SHARES OF 10p EACH
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
294.0 PENCE
22) Total number of shares or debentures over which options held
following this notification
456,639
23) Any additional information
24) Name of contact and telephone number for queries
ZOE EVANS, ASSISTANT COMPANY SECRETARY
01865 332600
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 20 DECEMBER 2002
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
POWDERJECT PHARMACEUTICALS PLC
2) NAME OF DIRECTOR
MR MUSTAPHA LEAVENWORTH BAKALI
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS IN 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
7) Number of shares/amount of
stock acquired
8) (N/A %)
of issued Class
9) Number of shares/amount
of stock disposed
10) ( N/A %)
of issued Class
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
20 DECEMBER 2002
18) Period during which or date on which exercisable
1 FEBRUARY 2006 - 31 JULY 2006
19) Total amount paid (if any) for grant of the option
#250.00 TO BE PAID MONTHLY FROM 1 FEBRUARY 2003 UNTIL 1 JANUARY 2006
UNDER POWERJECT PHARMACEUTICALS PLC SHARESAVE SCHEME
20) Description of shares or debentures involved: class, number.
3214 ORDINARY SHARES OF 10p EACH
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
294.0 PENCE
22) Total number of shares or debentures over which options held
following this notification
110,824
23) Any additional information
24) Name of contact and telephone number for queries
ZOE EVANS, ASSISTANT COMPANY SECRETARY
01865 332600
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 20 DECEMBER 2002
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
POWDERJECT PHARMACEUTICALS PLC
2) NAME OF DIRECTOR
MR CHARLES SWINGLAND
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS IN 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
7) Number of shares/amount of
stock acquired
8) (N/A %)
of issued Class
9) Number of shares/amount
of stock disposed
10) ( N/A %)
of issued Class
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
20 DECEMBER 2002
18) Period during which or date on which exercisable
1 FEBRUARY 2006 - 31 JULY 2006
19) Total amount paid (if any) for grant of the option
#250.00 TO BE PAID MONTHLY FROM 1 FEBRUARY 2003 UNTIL 1 JANUARY 2006
UNDER POWERJECT PHARMACEUTICALS PLC SHARESAVE SCHEME
20) Description of shares or debentures involved: class, number.
3214 ORDINARY SHARES OF 10p EACH
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
294.0 PENCE
22) Total number of shares or debentures over which options held
following this notification
940,824
23) Any additional information
24) Name of contact and telephone number for queries
ZOE EVANS, ASSISTANT COMPANY SECRETARY
01865 332600
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 20 DECEMBER 2002
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
POWDERJECT PHARMACEUTICALS PLC
2) NAME OF DIRECTOR
DR CLIVE DIX
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS IN 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
7) Number of shares/amount of
stock acquired
8) (N/A %)
of issued Class
9) Number of shares/amount
of stock disposed
10) ( N/A %)
of issued Class
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
20 DECEMBER 2002
18) Period during which or date on which exercisable
1 FEBRUARY 2006 - 31 JULY 2006
19) Total amount paid (if any) for grant of the option
#250.00 TO BE PAID MONTHLY FROM 1 FEBRUARY 2003 UNTIL 1 JANUARY 2006
UNDER POWERJECT PHARMACEUTICALS PLC SHARESAVE SCHEME
20) Description of shares or debentures involved: class, number.
3214 ORDINARY SHARES OF 10p EACH
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
294.0 PENCE
22) Total number of shares or debentures over which options held
following this notification
263,403
23) Any additional information
24) Name of contact and telephone number for queries
ZOE EVANS, ASSISTANT COMPANY SECRETARY
01865 332600
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 20 DECEMBER 2002
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFGMZZMGFGZZM
|